| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/05/2001 | CN1311630A Novel nucleosides having bicycle surgar moiety |
| 09/05/2001 | CN1311629A Inhibitors of transcription factor NF-KB |
| 09/05/2001 | CN1311628A Method and composition for the treatment of epidermal irritations and infections |
| 09/05/2001 | CN1311216A New polypeptide-human microtubulin 11 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311036A Mixed vaccine for anti-vibrisis of seawater cultivation amimals with its preparing method |
| 09/05/2001 | CN1311035A Recombination high efficiency composite interferon used as hepatitis B surface antigen and e antigen inhibitor |
| 09/05/2001 | CN1311029A Medicine for curing lung diseases and its preparing method |
| 09/05/2001 | CN1311021A Medicine for curing AIDS and acquired immunodeficiency syndrome and preparing method |
| 09/05/2001 | CN1311020A Medicine for curing tuberculosis and preparing method |
| 09/05/2001 | CN1311016A Traditional Chinese medicine for curing viral myocarditis and its preparing process |
| 09/05/2001 | CN1311015A Natural medicine for anti-virus, anti-heavy metals and anti-tumor |
| 09/05/2001 | CN1311011A Medicinal liquor for curing tinea |
| 09/05/2001 | CN1311003A Pearl compositions and its prepn. method |
| 09/05/2001 | CN1311001A Medicine for curing enteritis and bacillary dysentery |
| 09/05/2001 | CN1070488C Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
| 09/05/2001 | CN1070480C 2-amino-benzoxanones for treatment of viral infections |
| 09/05/2001 | CN1070371C Medicine for treating HIV-seropositive individuals medicine |
| 09/04/2001 | US6284888 From a mixture of a salt of 7-adca and a salt of vinyl-aca |
| 09/04/2001 | US6284884 Depolymerization and reacting with base to form de-n-acetylated polysaccharide; reacting with nitrosation agent |
| 09/04/2001 | US6284882 Myostatin gene promoter and inhibition of activation thereof |
| 09/04/2001 | US6284792 Formulation of valnemulin |
| 09/04/2001 | US6284767 Retroviral protease inhibiting compounds |
| 09/04/2001 | US6284753 Grampositve bacteria |
| 09/04/2001 | US6284749 Mixture of fungicide with chelate compound |
| 09/04/2001 | US6284742 Administering adenovirus and antibodies |
| 09/04/2001 | US6284737 Methods of treatment with anthracycline derivatives |
| 09/04/2001 | US6284736 Fungicides, antibiotic |
| 09/04/2001 | US6284540 Neuronal trophic support and cell differentiation by introducing nucleotide sequence |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284508 Glucuronoxylomannan (GXM)-O-acetylhydrolase of Cryptococcus neoformans and uses thereof |
| 09/04/2001 | US6284489 Enzymatic polypeptide for use in screening bactericides; wound healing agents; for prevention of bacterial infections |
| 09/04/2001 | US6284477 Diagnostic method of use of OMP26 antigen from Haemophilus influenzae |
| 09/04/2001 | US6284458 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 09/04/2001 | US6284456 Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor |
| 09/04/2001 | US6284289 Treatment of herpes infection with composition containing quaternary ammonium compound and an anti-viral agent |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | US6284256 Bordetella bronchiseptica vaccine |
| 09/04/2001 | US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/04/2001 | US6284254 Vaccines |
| 09/04/2001 | US6284252 Transdominant TAT variants of the human immunodeficiency virus |
| 09/04/2001 | US6284251 Bovine herpes virus |
| 09/04/2001 | US6284249 Fusion polypeptide having the C protein and E1 protein of hepatitis C virus |
| 09/04/2001 | US6284248 Immunogenic compositions comprising soluble, non-cleavable, chimeric HIV-1 gp160-variants |
| 09/04/2001 | US6284240 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 09/04/2001 | CA2037410C Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 08/30/2001 | WO2001063539A2 Anti-infective agents useful against multidrug-resistant strains of bacteria |
| 08/30/2001 | WO2001063280A2 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | WO2001063278A2 Antigenic fragments associated with stress-induced proteins and their use as vaccines |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062902A1 Hybrid cell vaccines |
| 08/30/2001 | WO2001062901A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062776A1 Hla binding peptides and their uses |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 08/30/2001 | WO2001062734A1 Process for producing quinolonecarboxylic acids and intermediates thereof |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062721A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062714A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062668A2 Sulfur containing compounds |
| 08/30/2001 | WO2001062312A1 Foam-forming wound dressing |
| 08/30/2001 | WO2001062297A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | WO2001062289A2 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001062283A2 Mucosal adjuvant formulation |
| 08/30/2001 | WO2001062275A1 Adjuvant treatment by in vivo activation of dendritic cells |
| 08/30/2001 | WO2001062255A1 Antiviral azaindole derivatives |
| 08/30/2001 | WO2001062195A1 Antibiotic and antifungal compositions |
| 08/30/2001 | WO2001014576A3 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 08/30/2001 | WO2001013927A3 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 08/30/2001 | WO2001012228A3 Compositions for treating viral infections, and methods therefor |
| 08/30/2001 | WO2001012127A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 08/30/2001 | WO2001009350A3 Genetically engineered bleb vaccine |
| 08/30/2001 | WO2001009174A3 Plant defensin variants |
| 08/30/2001 | WO2001008702A3 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018538 Silylating the corresponding carbamate compound; alkylation |
| 08/30/2001 | US20010018456 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis |
| 08/30/2001 | US20010018450 Amycomycin, a process for its production and its use as a pharmaceutical |
| 08/30/2001 | US20010018447 Il-8 receptor antagonists |
| 08/30/2001 | US20010018443 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 08/30/2001 | US20010018440 L-beta-dioxolane uridine analogs and methods for treating and preventing virus infections |
| 08/30/2001 | US20010018436 Pyrimidine derivatives |
| 08/30/2001 | US20010018430 Anticancer agents, psoriasis, restenosis, atherosclerosis |
| 08/30/2001 | US20010018418 Method of promoting angiogenesis |
| 08/30/2001 | US20010018212 Molecular weight of 14,000 to 24,000 daltons; treating infectious diseases and malignant tumors with said protein |
| 08/30/2001 | US20010018068 Water insoluble substrate comprising creped nonwoven layer and cleansing component (lathering surfactant); cleaning/ conditioning skin/hair; disposable; materials handling |
| 08/30/2001 | US20010018065 Administering drugs comprised of antibiotic, carrier, and oligosaccharide-support which binds and removes shiga-like toxins from gastrointestinal tract; Escherichia; enterotoxins; antidiarrhetics |
| 08/30/2001 | US20010018060 Use of particular fatty substances which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter |
| 08/30/2001 | DE10009408A1 Arzneimittel gegen virale Erkrankungen Medicines for viral diseases |
| 08/30/2001 | CA2683009A1 Use of il-18 inhibitors |
| 08/30/2001 | CA2401647A1 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | CA2400819A1 Method for producing quinolonecarboxylic acids and intermediates thereof |
| 08/30/2001 | CA2400636A1 Hybrid cell vaccines |